EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 17 November 2024. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q1 Un-audited): Consolidated EPS was Tk. 6.87 for July-September 2024 as against Tk. 6.77 for July-September 2023; Consolidated NOCFPS was Tk. 3.89 for July-September 2024 as against Tk. 9.54 for July-September 2023. Consolidated NAV per share was Tk. 149.76 as on September 30, 2024 and Tk. 142.05 as on June 30, 2024.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 673968d89f31fb035ffe9800
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.